Cite

HARVARD Citation

    Di Cesare, A. et al. (2020). SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis. Dermatologic therapy. 33 (3), p. n/a. [Online]. 
  
Back to record